by Danny KEMP
Outgoing U.S. President Joe Biden proposed Tuesday to give millions more Americans access to weight loss drugs — but Donald Trump’s incoming health chief looked set to shoot down the idea.
Under the massive U.S. public health insurance programs Medicare and Medicaid, drugs like Ozempic and Wegovy are, for the most part, only available for overweight people with diabetes or heart disease.
But the White House said Biden wanted to make the game-changing medications widely available as a treatment for obesity itself — expanding coverage to nearly 7.5 million older and lower-income Americans.
Biden proposes huge expansion of weight loss drug access
